PORTERFIELD, FETTIG & SEARS, LLC for ASTELLAS PHARMA US, INC.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to P.L. 96-517, the Bayh-Dole Act; issues related to drug pricing; issues related to Medicare Part D Coverage; HR 6505 Medicare Negotiation and Competitive Licensing Act
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has advocated and listed herein.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEREMY RABINOVITZ | — |
Government Issues GOV
S. 2482, Foreign Agents Registration Amendments Act of 2018; S.2039, Disclosing Foreign Influence Act; H.R. 4170, Disclosing Foreign Influence Act
Foreign entity interest: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the issues with respect to which Astellas Pharma US has advocated and listed herein.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JEREMY RABINOVITZ | — |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.